Nintedanib Impurity 30 | CAS 652140-02-8 - Request Quote
Nintedanib Impurity 30
| SZ CAT No: | SZ-N023046 |
| CAS No | 652140-02-8 |
| Mol.F. | C18H28N4O3 |
| Mol.Wt. | 348.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 30 is chemically Tert-butyl 4-(2-((4-aminophenyl)(methyl)amino)-2-oxoethyl)piperazine-1-carboxylate. Nintedanib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 652140-02-8
Purchase 652140-02-8
Order 652140-02-8
Enquire 652140-02-8
price of 652140-02-8
652140-02-8 Supplier
652140-02-8 Manufacturer
652140-02-8 Exporter
buy high quality Nintedanib Impurity 30
Purchase Nintedanib Impurity 30
Nintedanib Impurity 30 suppliers
Nintedanib Impurity 30 manufacturers
Nintedanib Impurity 30 price
Order Nintedanib Impurity 30
Enquire Nintedanib Impurity 30
Nintedanib Impurity 30 cost
Nintedanib Impurity 30 Supplier
Nintedanib Impurity 30 Distributor
Nintedanib Impurity 30 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 30 for ANDA Filing
Nintedanib Impurity 30 for Forced Degradation Studies
Nintedanib Impurity 30 Identification Standards
Nintedanib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.